Nina Capital — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
MedaSystems builds a software platform that automates workflows, collects real-world data, and connects physicians with pharmaceutical manufacturers to manage drugs under pre-approval and expanded-access pathways.
Digital HealthHealthtechMedical DevicesSaaSSilicon Valley, US
Brian Irwin(Chief Executive Officer)inJeffrey Thibeault(Chief Technology Officer)in
Co-investorsDebiopharm Innovation Fund
Leuko develops a noninvasive white blood cell monitor to track neutropenia risk in cancer patients and others undergoing treatment.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBoston, US
Ian Butterworth(Chief Technology Officer)inAurelien Bourquard(Chief Data Scientist)inAlvaro Sanchez-Ferro(Chief Medical Officer)inCarlos Castro-Gonzalez(Founder)inPaul Hartung(Director)in
BoardAmy Salzhauer(Director)in
Co-investorsGood Growth CapitalDorm RoomMassVenturesIAG Capital Partners
Segmed provides structured, de-identified medical imaging data and multimodal datasets from diverse populations to support research in AI and healthcare.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechMedical DevicesSan Francisco, US
Martin Willemink(Founder)inJie Wu(Founder)inMarinus Johannes Willemink(Executive Officer, Director)Wojciech Adam Koszek(Executive Officer, Director)Cailin Hardell(Founder)Cailin Kramer(Founder)in
Co-investorsBlumberg CapitalExpeditionsiGan PartnersMighty CapitalNovaCapitalSouth Quad+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






















